Table 3.
Clinical utility demonstration of each novel diagnostic.
| Outcome | Coefficient | p-Value |
|---|---|---|
| Linear Regression * | ||
| VectraDA—Intervention DxTx Score Improvement over Baseline | 12.5% | <0.001 |
| FirstStep—Intervention DxTx Score Improvement over Baseline | 10.9% | <0.001 |
| Logistic Regression * | ||
| ProMark—OR Intervention provides correct AS or AT to patient | 2.84 | 0.004 |
| SimpliPro Colon—OR Intervention orders diagnostic colonoscopy for patient | 3.88 | <0.001 |
* Multivariate model accounting for provider and patient characteristics; OR: Odds Ratio; AS: Active Surveillance; AT: Active Treatment